Minute Insight: Hedera DX Completes €14m Raise To Fund ML-Backed Liquid Biopsy Tech

Hedera DX’s liquid biopsy test uses machine learning to recommend drugs to patients based on a tumor’s circulating DNA profile.

Minute Insight
• Source: Informa/Alamy

Hedera DX has completed a €14m early-stage financing round backed by Top Harvest Capital, whose founder, Adam Ghobarah was an executive at Google and Google Ventures. 

Inventure, Air Street Capital, Amino Collective and GRIDS Capital also supported the deal.

More from Minute Insights

More from Medtech Insight